The research that did not happen

Prohibition did not only punish use.
It delayed knowledge.

That may be one of its deepest costs.

Cannabis was not merely kept away from consumers, patients, farmers or markets. It was also kept away from normal scientific development. Not completely. Research continued. Some scientists pushed through. Some discoveries were made. Cannabinoid chemistry advanced. Medical debates survived.

But the path was made harder than it needed to be.
And difficulty has consequences.

A plant cannot be understood properly when access is restricted, products are hard to study, funding is limited, researchers face administrative friction, and the material available for research does not match what people are actually using. The National Academies identified multiple barriers to cannabis and cannabinoid research, including restrictive regulations and policies, limited access to relevant products, funding limitations and methodological challenges.

That is not a cannabis slogan.
It is an institutional diagnosis.

The result is not simply “less research”.

• It is slower knowledge.
• Worse questions.
• Smaller studies.
• Delayed answers.
• Poorer education.
• More room for myth.
• More room for marketing.
• More room for panic.
• More room for people to decide from ideology because evidence arrived late.

This is the strange damage of prohibition. It does not only say “no”. It makes society less able to know what the “no” was based on.

For medicine, the cost is obvious. People used cannabis anyway: for pain, sleep, appetite, anxiety, nausea, seizures, pleasure, relief, habit, ritual, boredom, escape or necessity. Some benefited. Some were harmed. Some misunderstood what was happening. Some were sold promises. Some were given warnings without nuance.

What was missing was not opinion.
There was plenty of opinion.

What was missing was
enough well-structured knowledge.

• Which preparation?
• Which dose?
• Which route?
• Which condition?
• Which patient?
• Which risk?
• Which interaction?
• Which long-term outcome?
• Which product quality?

These are not abstract questions. They are the questions that separate medicine from rumour.

The same applies to cultivation.

When a plant is pushed outside legitimate agricultural education, growers do not stop learning. They learn in secrecy. Some become brilliant. Some become reckless. Knowledge moves through grow rooms, photocopied manuals, forums, trial and error, whispers, myths, mistakes and underground expertise.

That history produced real skill.
It also produced noise.

A legal agricultural crop can be studied openly: substrates, pests, irrigation, nutrient response, lighting, genetics, disease pressure, post-harvest handling, worker safety, environmental impact.

A prohibited plant learns in the dark.
That is not romantic.

• It is inefficient.
• It is costly.
• It is dangerous.

It also makes future education harder, because later generations inherit both the knowledge and the distortion together.

This is where LIBERA HERBA stands.

• Not to say cannabis is harmless.
• Not to say cannabis is miraculous.
• Not to say every prohibitionist was stupid or every activist was right.

The point is simpler and stronger: we should have known more by now.

• We should have had better medical answers.
• Better public-health data.
• Better product standards.
• Better cultivation research.
• Better risk education.
• Better language.
• Better historical memory.

Instead, cannabis became a field where law, fear and ideology often moved faster than evidence.

In the United States, the Schedule I classification placed cannabis in the most restrictive federal category, reserved for substances considered to have no currently accepted medical use and high abuse potential. That classification shaped research access, funding, approvals, material supply and institutional willingness. Even recent rescheduling debates have been framed partly around reducing research barriers and allowing better scientific understanding.

This does not mean rescheduling or legalisation solves everything.
It does not.

• A legal market can still produce bad science.
• A medical programme can still overpromise.
• A lab test can still mislead.
• A company can still use research as decoration.

But open research gives society a better chance to correct itself.

Closed knowledge does not protect the public.
It leaves the public with rumours.

For LIBERA HERBA, this is the educational conclusion:

• The plant deserved study before judgement.
• The patient deserved evidence before slogans.
• The grower deserved agronomy before secrecy.
• The public deserved risk literacy before panic.
• And the archive deserved honesty before myth.

Prohibition did not only delay cannabis.
It delayed our ability to speak about cannabis intelligently.

That is why education is not an accessory.
It is repair.